Shuni virus (SHUV) (*Peribunyaviridae*: *Orthobunyavirus*) was isolated in the 1960s from livestock, *Culicoides* midges, and a febrile child in Nigeria ([@R1],[@R2]). In South Africa, SHUV was identified as the causative agent of neurologic disease in horses ([@R3]); seropositivity was also demonstrated in 3.0% of veterinarians, suggesting human exposures ([@R4]). SHUV was subsequently identified in aborted livestock and cattle with neurologic disease in Israel, suggesting an extended range beyond Africa ([@R5],[@R6]). We investigated other potential susceptible species in South Africa.

The Study
=========

During February 2010--September 2018, a total of 101 whole blood, 71 serum, and 476 tissue specimens from 608 nonequine domestic animals, wildlife, and birds (19 fetuses, 118 juvenile and 471 adults) with unexplained neurologic or febrile disease or sudden unexplained death from across South Africa were submitted to the Zoonotic Arbo and Respiratory Virus Program, Centre for Viral Zoonoses, University of Pretoria (Pretoria, South Africa) as part of a passive zoonotic arbovirus surveillance program. We extracted RNA under Biosafety Level (BSL) 3 conditions using the QIAamp viral RNA mini kit (blood) or the RNeasy mini kit (tissue) (QIAGEN, <https://www.qiagen.com>), according to the manufacturer's recommendations. We screened all samples by a SHUV real-time reverse transcription PCR (rRT-PCR) ([@R7]) and a newly designed rRT-PCR targeting a conserved area of the S segment of the Simbu serogroup ([Appendix](#SD1){ref-type="local-data"}). We confirmed PCR-positive samples by Sanger sequencing (Inqaba Biotech, <https://www.inqababiotec.co.za>) and phylogenetic analyses ([Appendix](#SD1){ref-type="local-data"}). We also screened all specimens for West Nile (WNV), Wesselsbron ([@R8]), Middelburg (MIDV), Sindbis ([@R9]), and equine encephalosis viruses ([@R10]).

In addition, serum samples from African buffalo (*Syncerus caffer*) (n = 45) and white rhinoceros (*Ceratotherium simum*) (n = 48) from Kruger National Park were collected in March 2014 and June 2016, respectively, by South African National Parks and from wild Nile crocodiles (*Crocodylus niloticus*) (n = 34) from northern KwaZulu-Natal collected during 2009--2012 by the Faculty of Veterinary Sciences, University of Pretoria, as part of surveillance studies. We examined tissue samples from a SHUV PCR-confirmed positive buffalo (MVA43/10) microscopically under a light microscope using routinely prepared hematoxylin and eosin stained ([@R11]) histological sections at the Section of Pathology, Department of Paraclinical Sciences, Faculty of Veterinary Science, University of Pretoria. We subjected serum samples to an epitope-blocking ELISA (eb-ELISA) ([@R12],[@R13]) with modifications to detect antibodies to SHUV ([Appendix](#SD1){ref-type="local-data"}).

We calculated odds ratios (OR) and 95% CI in EpiInfo version 7.2.0.1 (<https://www.cdc.gov/epiinfo/index.html>). We excluded animals that were found dead, aborted, or stillborn from OR analysis.

We detected SHUV RNA in 15/608 (2.5%) animals tested from 10 different animal species: 12/361 (3.3%) wildlife, 2/196 (1.0%) nonequine domestic animals, and 1/51 avian species (2.0%) ([Table 1](#T1){ref-type="table"}). We detected SHUV in samples submitted from 2/62 (3.2%) white rhinoceroses, 2/50 (4.0%) sables, 1/15 (6.7%) warthog, 4/54 (7.4%) buffalo, 1/12 (8.3%) crocodiles, 1/5 (20.0%) giraffes, 1/4 (25.0%) springboks, 1/93 (1.1%) domestic bovids, and 1/10 (10.0%) alpacas ([Table 1](#T1){ref-type="table"}). We also detected SHUV in an exotic monal pheasant (1/13, 7.7%). Differential screening revealed co-infections with MIDV and WNV, suggesting that these arboviruses could co-circulate. A sable was also co-infected with *Theileria* sp. *sable* and *Theileria separate* ([Table 1](#T1){ref-type="table"}).

###### Animals that tested positive for Shuni virus by real-time reverse transcription PCR, South Africa, 2010--2018\*

  Animal type                                ID            No. positive/ no. tested   \% Positive (95% CI)   Province where submitted   Positive specimen   Clinical signs            Co-infection
  ------------------------------------------ ------------- -------------------------- ---------------------- -------------------------- ------------------- ------------------------- --------------
  Domestic bovid                             ZRU116/18     1/93                       1.1 (0.0--3.1)         North West                 Spleen              SUD                       
  White rhinoceros (*Ceratotherium simum*)   MVA11/10      2/62                       3.2 (0.0--7.6)         Limpopo                    CNS                 Neurologic                MIDV
  ZRU137/18                                                                           Free State                                                                                      
  Sable (*Hippotragus niger*)                ZRU419/17     2/50                       4.0 (0.0--9.4)         North West                 Spleen              Hemorrhagic               Theileriosis
  ZRU121/18                                                                           Limpopo                                                                                         
  Warthog *(Phaecocherus africanus)*         MVA35/10      1/15                       6.7 (0.0--19.3)        Limpopo                    CNS                 Neurologic, respiratory   
  Buffalo (*Syncerus caffra*)                MVA43/10      4/54                       7.4 (0.4--14.4)        Limpopo                    CNS, whole blood    Neurologic, respiratory   
  ZRU77/18                                                                            Limpopo                                                                                         
  ZRU97/18                                                                            Limpopo                                                                                         
  ZRU166/18                                                                           Limpopo                                                                                         
  Monal (*Lophophorus impejanus*)            ZRU119/18     1/13                       7.8 (0.0--22.2)        North West                 CNS                 SUD                       
  Crocodile (*Crocodylus niloticus*)         MVA08/10      1/12                       8.3 (0.0--24.0)        Limpopo                    CNS                 Neurologic                
  Alpaca (*Vicugna pacos*)                   ZRU172/18     1/10                       10.0 (0.0--28--6)      Western Cape               CNS                 Neurologic, respiratory   
  Giraffe (*Giraffa camelopardalis*)         ZRU87/18      1/5                        20 (0.0--55.0)         North West                 Whole blood         SUD                       WNV
  Springbok (*Antidorcus marsupialis*)†      ZRU261/17/3   1/4                        25.0 (0.0--67.4)       Gauteng                    Spleen              Neurologic                
  Wildlife                                                 12/361                     3.3 (1.5--5.1)                                                                                  
  Domestic animals                                         2/196                      1.1 (0.0--2.5)                                                                                  
  Avian                                                    1/51                       2.0 (0.0--5.8)                                                                                  
  Total                                                    15/608                     2.5 (1.2--3.7)                                                                                  

\*CNS, central nervous system; MIDV, Middelburg virus; SUD, sudden unexpected death; WNV, West Nile virus. †Cluster with Sango virus.

In 9/15 (60.0%, 95% CI 35.2%--84.8%) positive infections, we detected SHUV in the central nervous system (CNS) ([Table 1](#T1){ref-type="table"}), indicating passage across the blood--brain barrier, which suggests SHUV as the likely causal agent of the observed neurologic signs. This finding suggests that SHUV is not just an agent of subclinical infections or reproductive problems, such as abortion, as previously reported ([@R5],[@R14]), but is also the likely etiology for neurologic disease in these species, as previously described for horses ([@R3]) and cattle ([@R6]). We did not detect SHUV RNA in aborted (n = 24) or stillborn (n = 16) animals. Eleven SHUV-positive animals showed neurologic signs (OR 1.8, 95% CI 0.2--14.4), with 2 animals also reported to be pyrexic (OR 2.0, 95% CI 0.4--9.4) or showing respiratory signs (OR 1.0, 95% CI 0.2--4.8) ([Table 2](#T2){ref-type="table"}). Three SHUV-positive animals were found dead (OR 1.8, 95% CI 0.5--6.4) ([Table 2](#T2){ref-type="table"}). Specific neurologic signs associated with SHUV infection included hind limb paresis progressing to quadriparesis with normal mentation (OR 6.7, 95% CI 2.0--22.5) ([Table 2](#T2){ref-type="table"}).

###### Clinical signs reported in wildlife, nonequine domestic animals, and birds upon submission to the Centre for Viral Zoonoses, South Africa, 2010--2018\*

  Sign                     SHUV positive (%), n = 12   SHUV negative (%), n = 496   Odds ratio (95% CI)   p value†
  ------------------------ --------------------------- ---------------------------- --------------------- ----------
  Neurologic signs         11 (91.7)                   415 (83.7)                   1.8 (0.2--14.4)       0.9
  Ataxia                   2 (16.7)                    102 (20.6)                   0.8 (0.2--3.5)        1
  Paralysis                3 (25.0)                    61 (12.3)                    2.3 (0.6--8.8)        0.4
  Quadriparesis            8 (66.7)                    112 (22.6)                   6.7 (2.0--22.5)       \<0.05
  Recumbence               2 (16.7)                    103 (20.8)                   0.7 (0.2--3.4)        1
  Pyrexia                  2 (16.7)                    44 (8.9)                     2.0 (0.4--9.4)        0.7
  Respiratory/dyspnea      2 (16.7)                    79 (15.9)                    1.0 (0.2--4.8)        1
  Hemorrhage               1 (8.3)                     10 (2.0)                     4.3 (0.5--36.7)       0.6
  Congenital deformities   0                           7 (1.4)                      Undefined             1
  Outcomes                 n = 15                      n = 593                                            
  SUD                      3 (20.0)                    74 (12.5)                    1.8 (0.5--6.4)        0.6
  Abortion                 0                           24 (4.1)                     Undetermined          1
  Stillbirth               0                           16 (6.7)                     Undetermined          1

\*SHUV, Shuni virus; SUD, sudden unexpected death.  †p values \<0.05 are regarded as significant.

Positivity of infection was highest in the North West (4/47, 8.5% of samples submitted from North West), followed by Limpopo Province (8/132, 6.1%) ([Table 1](#T1){ref-type="table"}; [Appendix](#SD1){ref-type="local-data"} Figure 1). SHUV was detected only in 2010 (4/15, 26.7%), 2017 (2/15, 13.3%), and 2018 (9/15, 60.0%) despite continuous surveillance throughout the years, suggesting that outbreaks may be sporadic rather than annual. SHUV PCR positives were detected during April--September in each of the 3 years ([Appendix](#SD1){ref-type="local-data"} Figure 2).

Necropsy examination on the buffalo showed no specific macroscopic lesions on histopathology examination of brain tissue ([Figure 1](#F1){ref-type="fig"}). Pathological changes that could be detected in regions of the brain included mild white matter cerebro--cerebellar gliosis, especially microglial, associated with considerable glial apoptotic activity and occasional perivascular hemorrhage. In the spinal cord, occasional single neuronal necrosis (chromatolysis) and perineuronal hypereosinophilic bodies affecting the dorsal horns of the gray matter were distinctive. This finding seemed to be most severe in the lumbar spinal region. No evidence of demyelination or major immunological reaction was observed, apart from occasional perivascular lymphocytes. Development of appropriate antibodies for immunohistochemistry or probes for in situ hybridization may further describe the pathology of SHUV in animal tissue.

![Histopathological changes in formalin-fixed brain tissue of a Shuni virus PCR-positive buffalo (MVA73/10) in South Africa that showed neurologic signs (original magnification 1000×). A, B) Cerebral white matter micro/astrogliosis and cytogenic edema (arrows). C, D) Glial (suspected oligodendroglia) apoptosis (arrows). E, F) Perineural hypereosinophilic bodies (arrows); perivascular and neuropil hemorrhage (circle); single-cell neuronal degeneration (chromatolysis) (star).](19-0770-F1){#F1}

We used phylogenetic analyses on the small segment of the Simbu serogroup to verify the molecular results. All novel sequences from this study, with 1 exception, were closely related to SHUV strains identified in horses in South Africa ([@R3]) in clade 1a of lineage I within the Simbu serogroup (bootstopping: posterior probabilities = 89:0.99) ([Figure 2](#F2){ref-type="fig"}). An isolate from a springbok (ZRU261_17_3) clustered with Sango virus (bootstopping: posterior probabilities = 67:0.94). P-distance analysis based on the partial small segment demonstrated few nucleotide differences between novel SHUV strains and reference strains (98.0%--100.0% identity). Wildlife specimens were submitted mostly from dead animals that were already undergoing postmortem cytolysis, inhibiting further genetic analysis and isolation of the virus. The use of a PCR designed to detect Simbu group/orthobunyavirus genus PCR rather than SHUV-specific PCR facilitated detection of these infections.

![Phylogram of clade 1a, lineage I, of the Simbu serogroup (*15*) recovered from maximum-likelihood and Bayesian analyses of the small segment for SHUV isolates from wildlife and nonequine domestic animals, South Africa and reference sequences. Bootstrap values (maximum likelihood \>60) and posterior probabilities (\>0.8) are displayed on branches as support values. GenBank accession numbers for sequences from this study (black circles): MVA11_10_Rhinoceros, JQ726395; MVA08_10_Crocodile, JQ726396; MVA43_10_Buffalo, JQ726397; MVA35_10_Warthog, JQ726398; ZRU077_18_Buffalo, MK114084; ZRU121_18_Sable, MK114085; ZRU137_18_Rhinoceros, MK114086. GenBank accession numbers, virus types, and locations for reference sequences: An10107, AF362405, SHUV Nigeria; AINOV, M22011, Japan; VRC713423--2 KAIV, AF362394, India; SAE72_09_Horse, HQ610138, South Africa; SAE27_10_Horse, HQ610139, South Africa; SAE38_10_Horse, HQ610140, South Africa; SAE39_10_Horse, HQ610141, South Africa; SAE48_10_Horse, HQ610142, South Africa; SAE109_10_Horse, HQ610143, South Africa; SAE18_09_Horse, KC510272, South Africa; SAE87_11_Horse, KC525997, South Africa; Shuni_215_14, KP900859, Israel; Shuni_263_14, KP900860, Israel; Shuni_267_2\_14, KP900861, Israel; Shuni_267_4\_14, KP900862, Israel; Shuni_273_14, KP900865, Israel; Shuni_274_14, KP900867, Israel; Shuni_275_1\_14, KP900869, Israel; Shuni_275_2\_14, KP900871, Israel; Shuni_2417_1\_14, KP900872, Israel; Shuni_2417_2\_14, KP900875, Israel; Shuni_2504_1\_14, KP900877, Israel; Shuni_2504_2\_14, KP900878, Israel; Shuni_2504_3\_14, KP900882, Israel; 2504_3\_14, KU937313, Israel; SHUV_ISR-274_14, KT946779, Israel; SHUV_ISR-2417_2\_14, KT946780, Israel; ISR-129_16, MF361846, Israel; ISR-242_16, MF361849, Israel; ISR-2067_16, MF361852, Israel; ISR-2162_16, MF361855, Israel; CSIRO 110, MH484320, Australia; An5077, AF362402, Nigeria. AINOV, ainovirus; KAIV, kaikalurvirus; PEAV, Peaton virus; SANV, Sango virus; SHUV, Shuni virus..](19-0770-F2){#F2}

We detected antibodies to SHUV by an eb-ELISA in 3/44 (6.8%) African buffalo and 2/48 (4.2%) white rhinoceroses but none in crocodiles. SHUV-specific IgG was confirmed, using microtiter virus neutralization assay, in 1 buffalo and 1 rhinoceros. Two of 3 buffalo and 1 rhinoceros positive for SHUV epitope antibodies were negative by microtiter virus neutralization assay, suggesting that these antibodies may have been elicited in response to closely related orthobunyavirus. Confirmation for the third buffalo was not possible because of depleted serum.

Conclusion
==========

Our findings suggest that SHUV may have a wide host range, including several wildlife and domestic species, and should be included in the differential diagnosis of neurologic disease in animals. This study highlights the role of this virus as a potential emerging zoonotic pathogen in Africa that warrants increased surveillance and further investigation. Future epidemiologic studies would benefit from an increased sample size and more extensive serosurveys. Investigation of human infections may define SHUV's importance as a zoonosis. The causative link between clinical manifestations in the various species and the evidence of SHUV infection must be regarded with caution because other possible infectious and noninfectious etiologies were not excluded by comprehensive investigations in all cases.

###### Appendix

Additional information about the study of Shuni virus in wildlife and nonequine domestic animals, South Africa.

*Suggested citation for this article*: Steyn J, Motlou P, van Eeden C, Pretorius M, Stivaktas VI, Williams J, et al. Shuni virus in wildlife and nonequine domestic animals, South Africa. Emerg Infect Dis. 2020 July \[*date cited*\]. <http://dx.doi.org/10.3201/eid2607.190770>

We thank participating veterinarians and veterinary pathologists from South Africa, as well as L.P. Snyman, for the help with the phylogenetic analyses.

This research was funded through the US CDC Global Disease Detection grant for Zoonotic arboviruses under grant no. 1U19GH000571-01-GDD Non-Research CoAg with the NHLS project 23 and UP Zoonotic Arbo and Respiratory virus program, 2012--2015, and by cooperative agreement no. 5 NU2GGH001874-02-00 with the University of Pretoria, 2015--2016. Buffalo samples were financed through BBSRC-USDA funding (grant no. BB/L011085/1) and transported under a Red Cross permit (LDK2016/9/1) to the BSL3 lab at CVZ. J Steyn received doctoral scholarship form the NRF (grant no. 95175), the Meat Industry Trust (grant no. IT8114/98), the Poliomyelitis Research Foundation (grant no. 15/112).

This study was cleared by section 20 (12/11/1/1) approval through the Department of Agriculture Forestry and Fisheries (DAFF) (2014-October 2018) (M.V.) as well as by the animal ethics (H12-16) and section 20 (V057-15)(2017) of the University of Pretoria and the PhD research committee.

Dr. Steyn is a virologist and PhD candidate at the Centre for Viral Zoonoses at the University of Pretoria, South Africa. Her primary research focuses on investigating arboviruses with zoonotic potential at human--animal interface areas.
